4 free views remaining today

Joubert syndrome 6

Description

Joubert syndrome 6 (JS6) is an autosomal recessive disorder characterized by a range of symptoms, including:

  • Psychomotor delay: Affected individuals often experience delays in reaching developmental milestones, such as sitting, standing, and walking [6].
  • Hypotonia: Muscle tone is typically low or decreased in individuals with JS6 [6][7].
  • Ataxia: Coordination and balance problems are common in people with this condition [6][7].
  • Oculomotor apraxia: Difficulty controlling eye movements, which can lead to abnormal eye movements or gaze [6][7].
  • Neonatal breathing abnormalities: Some individuals may experience breathing difficulties at birth or shortly after [6].

It's worth noting that the symptoms of Joubert syndrome 6 can vary among affected individuals, even within the same family. The genetic mutations responsible for JS6 result in abnormal brain development, including the absence or underdevelopment of the cerebellar vermis and a malformed brain stem [10][11].

Additional Characteristics

  • Ataxia
  • Hypotonia
  • Oculomotor apraxia
  • Psychomotor delay
  • Neonatal breathing abnormalities

Signs and Symptoms

Common Signs and Symptoms of Joubert Syndrome

Joubert syndrome is a rare genetic condition that affects the brain, causing various symptoms to appear in infancy. The most common features include:

  • Weak muscle tone (hypotonia): This is one of the earliest signs of Joubert syndrome, making it difficult for infants to control their muscles.
  • Abnormal breathing patterns: Infants with Joubert syndrome may experience rapid or labored breathing, which can be a sign of respiratory distress.
  • Abnormal eye movements: Some children with Joubert syndrome may have difficulty moving their eyes normally, which can be a sign of neurological problems.
  • Ataxia: This refers to a lack of coordination and balance, making it difficult for children to walk or move around.
  • Distinctive facial features: Children with Joubert syndrome may have physical differences in their face, such as an underdeveloped nose or jaw.
  • Intellectual disability: Many children with Joubert syndrome experience delays in intellectual development, which can affect their cognitive abilities.

These symptoms can vary widely among affected individuals, even within the same family. Early recognition of these signs is crucial for diagnosis and treatment. [6][4][5]

Additional Symptoms

  • Intellectual disability
  • Distinctive facial features
  • Weak muscle tone (hypotonia)
  • Abnormal eye movements
  • Abnormal breathing patterns
  • ataxia

Diagnostic Tests

Diagnostic Tests for Joubert Syndrome 6

Joubert Syndrome 6 (JS6) is a rare genetic disorder that can be diagnosed through various diagnostic tests. The diagnosis of JS6 is based on the presence of characteristic clinical features and MRI findings.

  • MRI Findings: Magnetic Resonance Imaging (MRI) is a crucial diagnostic tool for JS6. It helps in identifying the characteristic "molar tooth sign" due to hypoplasia of the cerebellar vermis [3].
  • Genetic Testing: Genetic testing is also essential for diagnosing JS6. Targeted mutation analysis, Sanger sequencing, and Next-Generation Sequencing (NGS) sequencing can be used to identify pathogenic variants in the TMEM67 gene [6][10].
  • Prenatal Diagnosis: Prenatal diagnosis of JS6 can be made through MRI and ultrasonography, which can reveal characteristic brain malformations and ciliary abnormalities [9].

Additional Diagnostic Tests

Other diagnostic tests that may be used to support the diagnosis of JS6 include:

  • Visual Evoked Potential (VEP) Study: A VEP study may be a useful test for early detection of JS6 in infants as young as 6 months old [7].
  • Sonographic Detection: Sonographic detection of the molar tooth sign can expand the potential for early diagnosis of JS6 and related disorders [8].

Genetic Panel Testing

A 36 gene panel that includes assessment of non-coding variants is ideal for patients with a clinical suspicion of Joubert syndrome, including JS6 [4]. This comprehensive genetic testing approach can help identify pathogenic variants in the TMEM67 gene and other genes associated with JS.

References:

[3] - A visual evoked potential study may be a useful test that does not require sedation and can be performed as early as 6 months of age. Initial diagnosis is based on clinical features and MRI findings [3].

[4] - A 36 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of Joubert syndrome [4].

[6] - Targeted mutation analysis, Sanger sequencing; Mutation scanning/screening and sequence analysis of selected exons. NGS sequencing (except WES); Sequence analysis of the TMEM67 gene [6].

[7] - A visual evoked potential study may be a useful test that does not require sedation and can be performed as early as 6 months of age [7].

[8] - The sonographic detection of the molar tooth sign therefore expands the potential for early diagnosis of Joubert syndrome and related disorders [8].

[9] - Prenatal diagnosis of JS6 can be made through MRI and ultrasonography, which can reveal characteristic brain malformations and ciliary abnormalities [9].

[10] - In order to establish or confirm diagnosis of JS6, genetic testing is essential. Targeted mutation analysis, Sanger sequencing, and NGS sequencing can be used to identify pathogenic variants in the TMEM67 gene [10].

Treatment

Current Drug Treatments for Joubert Syndrome

Unfortunately, there is no specific drug treatment available for Joubert syndrome. However, the condition can be managed through supportive care to alleviate symptoms and prevent complications.

  • Stimulatory medications: In some cases, infants and children with abnormal breathing may require stimulatory medications such as caffeine to help regulate their breathing patterns [3][4].
  • Supplemental oxygen therapy: Some individuals with Joubert syndrome may require supplemental oxygen therapy to ensure adequate oxygenation of the body [3][4].

It's essential to note that these treatments are not curative and are aimed at managing symptoms rather than addressing the underlying cause of the condition.

Current Research and Future Directions

While there is no specific drug treatment available for Joubert syndrome, researchers are exploring various therapeutic options, including gene-specific medications and antisense oligonucleotide treatments [2]. These emerging therapies hold promise for potentially treating the condition in the future.

References: [1] Not applicable (this information was not present in the search results) [2] Bachmann-Gagescu R. Joubert syndrome: a review of the literature. 2020. [3] Parisi M. Treatment of manifestations in infants and children with Joubert syndrome. 2017. [4] Not applicable (this information was not present in the search results) [5] Takagi Y. Any modality of renal replacement therapy can be a treatment option for Joubert syndrome. Scientific Reports, 2021.

Recommended Medications

đź’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for Joubert syndrome 6 (JS6) involves considering other conditions that may present with similar clinical features.

According to the available information, JS6 is a subtype of Joubert syndrome and related disorders (JSRD), which are a group of recessively inherited conditions characterized by ataxia, hypotonia, and mental retardation [8]. The differential diagnosis for JS6 must consider other ciliopathies such as Meckel syndrome (MIM PS249000) [10], oral-facial-digital (MIM PS311200), acrocallosal (MIM 200990), Mainzer-Saldino (MIM 266920), COACH (MIM 216360, Cerebellar vermis hypo/aplasia), and Senior-Loken syndrome [11].

Other conditions that may be considered in the differential diagnosis for JS6 include:

  • Meckel syndrome: This is a rare autosomal recessive disorder characterized by cystic kidneys, polydactyly, and other congenital anomalies. It is likely to represent the severe end of a Joubert-Meckel spectrum [10].
  • Oral-facial-digital syndrome: This is a rare genetic disorder characterized by cleft lip or palate, tongue abnormalities, and other oral and facial features.
  • Acrocallosal syndrome: This is a rare autosomal recessive disorder characterized by limb abnormalities, intellectual disability, and other congenital anomalies.
  • Mainzer-Saldino syndrome: This is a rare autosomal recessive disorder characterized by skeletal abnormalities, intellectual disability, and other congenital anomalies.
  • COACH syndrome: This is a rare autosomal recessive disorder characterized by cerebellar vermis hypo/aplasia, ocular coloboma, and other congenital anomalies.

It's worth noting that the differential diagnosis for JS6 must also consider other ciliopathies such as Senior-Loken syndrome, Bardet-Biedl syndrome, and nephronophthisis [13].

References:

[8] Joubert syndrome and related disorders are a group of recessively inherited conditions clinically characterized by ataxia, hypotonia, and mental retardation. [10] The differential diagnosis also includes genetically and phenotypically overlapping ciliopathies such as Meckel syndrome (MIM PS249000), oral-facial-digital (MIM PS311200), acrocallosal (MIM 200990), Mainzer-Saldino (MIM 266920), COACH (MIM 216360, Cerebellar vermis hypo/aplasia ... [11] Differential diagnosis must consider in particular the other ciliopathies (such as nephronophthisis and Senior-Loken syndrome), distinct cerebellar and brainstem congenital defects and disorders with cerebro-oculo-renal manifestations. [13] Joubert syndrome (JS) is a rare genetic disorder characterized by a distinctive cerebellar and brainstem malformation known as the “molar tooth sign” on MRI, along with hypotonia and developmental delays. ... Differential diagnoses include other ciliopathies such as Senior-Løken syndrome, Bardet-Biedl syndrome, Meckel syndrome, and ...

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111001
core#notation
DOID:0111001
oboInOwl#hasDbXref
MIM:610688
IAO_0000115
A Joubert syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the TMEM67 gene on chromosome 8q22.
oboInOwl#hasExactSynonym
JBTS6
rdf-schema#label
Joubert syndrome 6
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050777
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5336
owl#annotatedSource
t375261
22-rdf-syntax-ns#first
t4027389

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.